Hidekata Yasuoka
Toyoake, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
The guide for the diagnosis and treatment of connective tissue disease-associated interstitial lung disease 2025.
Journal: Respiratory investigation
Published: January 31, 2026
Comparison of biomechanical assessment between upright and supine inspiratory-expiratory area-detector CT in progressive pulmonary fibrosis.
Journal: European radiology experimental
Published: August 22, 2025
Immunosuppressive Therapy for Pulmonary Arterial Hypertension Associated with Connective Tissue Diseases: Insights from Japanese Registry.
Journal: Advances in therapy
Published: August 21, 2025
Clinical and Epidemiological Features of Juvenile-Onset Systemic Sclerosis From a Nationwide Survey in Japan.
Journal: The Journal of rheumatology
Published: August 06, 2025
Circulating microRNAs associated with tumour necrosis factor or fibloblast-like synoviocyte predict cartilage damage in early rheumatoid arthritis treated with methotrexate plus adalimumab: a subanalysis of the MIRACLE study.
Journal: Clinical and experimental rheumatology
Published: April 14, 2025
Characteristics of patients with systemic sclerosis with aspiration: A single-center study.
Journal: Journal of scleroderma and related disorders
Published: March 31, 2025
Discontinuation vs. continuation of concomitant methotrexate in patients with rheumatoid arthritis on certolizumab pegol: results from a randomised, controlled trial.
Journal: Arthritis research & therapy
Published: January 15, 2025
Treatment patterns and clinical profile in progressive pulmonary fibrosis: a Japanese cross-sectional survey.
Journal: Frontiers in medicine
Published: November 11, 2024
The patient journey and burden of disease in progressive pulmonary fibrosis in Japan: a cross-sectional survey.
Journal: Frontiers in medicine
Published: November 11, 2024
Association of methotrexate polyglutamates concentration with methotrexate efficacy and safety in patients with rheumatoid arthritis treated with predefined dose: results from the MIRACLE trial.
Journal: Annals of the rheumatic diseases
Published: July 01, 2024
CCR4+Tfh2 cells specifically produce IL-4 driving the pathological reaction in IgG4-related disease.
CCR4+Tfh2 cells specifically produce IL-4 driving the pathological reaction in IgG4-related disease.
Journal: Clinical and experimental rheumatology
Published: May 28, 2024
Last Updated: 09/26/2026